LCM
GBIO

Laurion Capital Management’s Generation Bio GBIO Stock Holding History

Laurion Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,135
Closed -$2.29M – 627
2021
Q3 		$2.29M Sell
9,135
-2,725
-23% -$653K 0.01% 424
2021
Q2 		$3.19M Sell
11,860
-640
-5% -$191K 0.02% 328
2021
Q1 		$3.56M Buy
+12,500
New +$4M 0.02% 370

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Laurion Capital Management's GBIO Position: Q4 2021 in Review

Laurion Capital Management sold out of Generation Bio (GBIO) in Q4 2021, closing a stake of 9,135 shares — an estimated $2.29M sold.

Laurion Capital Management first reported a position in GBIO in Q1 2021 and held it in 3 quarters. The position peaked at $3.56M in Q1 2021. 88 funds tracked by Wall St. Rank hold GBIO as of Q4 2021.

  • Laurion Capital Management reported no remaining Generation Bio position as of Q4 2021 after selling out during the quarter.
  • Laurion Capital Management sold 9,135 Generation Bio shares in Q4 2021, an estimated $2.29M.
  • Laurion Capital Management first reported a position in Generation Bio in Q1 2021 and held it in 3 quarters.
  • Laurion Capital Management's Generation Bio position peaked at $3.56M in Q1 2021.
  • 88 funds tracked by Wall St. Rank held Generation Bio as of Q4 2021.

Based on Laurion Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.